Pharmafile Logo
Pharmafocus logo
Advanced Search

patisran

Showing 1 posts of 1 posts found.

Alnylam soars on likely first RNAi treatment approval

September 22, 2017
Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …

News
The Gateway to Local Adoption Series

Latest content

NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases

July 30, 2026

EMA selects TrialAssure anonymisation platform for clinical trial documents

July 30, 2026

Researchers develop new antifungal compounds with improved safety profile

July 29, 2026

Lonza and Engitix partner to develop next-generation antibody-drug conjugates

July 28, 2026

Simris Group appoints Tiffany J Vora as Strategic Advisor

July 28, 2026